GEMCITABINE

NDC 71288-113 · Meitheal Pharmaceuticals Inc.

Generic nameGEMCITABINE HYDROCHLORIDE

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)GEMCITABINE HYDROCHLORIDE

Strength200 mg/1

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

71288-113-10 — 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-113-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg Medicare Part B payment limit (ASP + 6%): $2.88

FDA lists these products with the same active ingredient.

25021-239 — gemcitabine, 55111-686 — gemcitabine, 55111-687 — gemcitabine, 63323-102 — GEMCITABINE, 63323-125 — GEMCITABINE, 63323-126 — GEMCITABINE, 67457-616 — GEMCITABINE HYDROCHLORIDE, 67457-617 — GEMCITABINE HYDROCHLORIDE, 67457-618 — GEMCITABINE HYDROCHLORIDE, 68001-342 — GEMCITABINE, 68001-348 — GEMCITABINE, 68001-359 — GEMCITABINE, 68083-148 — gemcitabine hydrochloride, 68083-149 — gemcitabine hydrochloride, 71288-114 — GEMCITABINE HYDROCHLORIDE, 71288-117 — Gemcitabine hydrochloride, 82511-008 — Gemcitabine hydrochloride, 82511-009 — Gemcitabine hydrochloride, 83831-123 — Gemcitabine, 83831-124 — Gemcitabine, +13 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.